Refractory esophagitis caused by Candida nivariensis: second description of this yeast in Brazil and a literature review

Future Microbiol. 2022 Aug:17:903-915. doi: 10.2217/fmb-2021-0109. Epub 2022 Jun 24.

Abstract

Candida nivariensis caused refractory esophagitis in a 36-year-old Brazilian man coinfected with HIV and Leishmania. A literature review on this rare fungal pathogen is also presented. The diagnosis was made, and pathogen identification was performed using matrix-assisted laser desorption ionization-time of flight mass spectrometry and sequencing of the LSU/26S region. An antifungigram was performed using broth microdilution. A literature search of PubMed was performed. The causative agent, C. nivariensis, was resistant to fluconazole and voriconazole. The patient's condition worsened considerably, and he passed away. This is the second report of this Candida species in Brazil and the first case reported worldwide of refractory esophagitis in a patient coinfected with HIV and Leishmania. The case illustrates the importance of precise identification and antifungal susceptibility testing when isolating this emerging pathogen.

Keywords: HIV; Leishmania; antifungal resistance; candidiasis; emerging pathogen.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Brazil
  • Drug Resistance, Fungal
  • Esophagitis* / diagnosis
  • Esophagitis* / drug therapy
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Saccharomyces cerevisiae
  • Saccharomycetales

Substances

  • Antifungal Agents
  • Fluconazole

Supplementary concepts

  • Candida nivariensis